Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Numbers & Percentages of Evaluable Patients

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Sep 02, 2022 11:19am

188 Views

Post# 34938128

RE:RE:Numbers & Percentages of Evaluable Patients

riverrrow wrote: So does this mean that there was a 90 day period during which only 1 patient was treated? Is this why there's no buying intetest in spite of the good results?

I think most investors/traders and analysts take the Summer off. This last NR would have been under their radar anyway, as it was just a routine financial... So, yes only 1 treated in that period, yet there are 4 more out there due to get to 90day at some point... More improvement in the numbers moving through, IMO.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading